AC

Annandale Capital Portfolio holdings

AUM $542M
1-Year Return 10.03%
This Quarter Return
+4.61%
1 Year Return
+10.03%
3 Year Return
+43.01%
5 Year Return
10 Year Return
AUM
$316M
AUM Growth
+$13.1M
Cap. Flow
+$7.1M
Cap. Flow %
2.25%
Top 10 Hldgs %
43.68%
Holding
141
New
7
Increased
34
Reduced
25
Closed
8

Sector Composition

1 Energy 19.41%
2 Technology 9.88%
3 Financials 9.77%
4 Communication Services 7.85%
5 Consumer Discretionary 6.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WHWK
126
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$87.7M
$72K 0.02%
10,000
PVLA
127
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$65K 0.02%
838
PASG icon
128
Passage Bio
PASG
$21.9M
$52K 0.02%
2,717
LENZ
129
LENZ Therapeutics
LENZ
$1.15B
$44K 0.01%
2,561
EIGR
130
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$33K 0.01%
1,223
MDNA
131
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$26K 0.01%
40,000
LPTX icon
132
Leap Therapeutics
LPTX
$12.4M
$14K ﹤0.01%
4,000
LITS
133
Lite Strategy, Inc. Common Stock
LITS
$92.6M
$11K ﹤0.01%
2,493
-2,507
-50% -$11.1K
CVX icon
134
Chevron
CVX
$317B
-1,218
Closed -$219K
EQT icon
135
EQT Corp
EQT
$31.5B
-7,365
Closed -$249K
ITRN icon
136
Ituran Location and Control
ITRN
$713M
-10,000
Closed -$211K
IVV icon
137
iShares Core S&P 500 ETF
IVV
$678B
-716
Closed -$275K
KLAC icon
138
KLA
KLAC
$130B
-3,123
Closed -$1.18M
STR
139
DELISTED
Sitio Royalties
STR
-7,931
Closed -$229K
MRO
140
DELISTED
Marathon Oil Corporation
MRO
-9,400
Closed -$254K
RDHL
141
Redhill Biopharma
RDHL
$3.37M
-25
Closed -$4K